Newsroom

ACHP Joins Campaign for Sustainable Rx Pricing

“ACHP’s expertise as a national leader in tackling health care challenges is invaluable and we are glad to have them on board,” said CSRxP Executive Director John Rother. “Patient-centered community health systems work with families struggling every day to afford costly prescription drugs, and those medications are only getting more expensive.”

Read more

CSRxP Statement on Mylan’s EpiPen Announcement

After weeks of intense scrutiny on its pricing practices, Mylan Pharmaceuticals announced today that it would offer a coupon to patients that cannot afford life-saving EpiPens. Mylan’s public relations move does nothing address the real affordability problem facing American families: the underlying price of the medication.

Read more

New CMS Report Shows Prescription Drug Price Hikes Are Adding Up for Taxpayers

“Prescription drug prices rise faster than inflation every year and taxpayers are footing the bill for these higher prices. Even if you don’t take a medication, you’re paying for it,” Rother noted.

Read more

Analysis Shows New Cholesterol Medications Are Not Cost Effective

“The dangerous trend of high-priced drugs has to be reversed and a common-sense solution like measuring the value and cost-effectiveness of medications is one necessary step to fix the broken prescription drug market, but it must also be combined with increased transparency and competition.”

Read more